scholarly journals Ebola Virus Disease Epidemic: What Can the World Learn and Not Learn from West Africa?

2014 ◽  
Vol 3 (1) ◽  
Author(s):  
Romuladus Azuine
Author(s):  
Samir Dervisevic

This chapter gives an overview on the recent outbreak of Ebola Virus Disease in West Africa which has lasted for over seventeen months. The Ebola virus has been implicated as a causative agent of viral haemorrhagic fever occurring in Central Africa over the last thirty-nine years. However, the Ebola virus has not previously been recognised as an endemic virus causing outbreaks of viral illness in West Africa. The start of what was to become the largest Ebola virus disease (EVD) outbreak in known history was first reported to the World Health Organization (WHO) on the 23rd of March 2014 and since then it has transformed into an unprecedented and severe epidemic affecting the three countries of West Africa (Guinea, Liberia and Sierra Leone). The emergence of this lethal virus in a setting of profound poverty, a dysfunctional public-health and a weak government infrastructure alarmed the wider world and caused dread from an uncontrollable spread.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
T. R. W. Tipton ◽  
Y. Hall ◽  
J. A. Bore ◽  
A. White ◽  
L. S. Sibley ◽  
...  

AbstractZaireebolavirus (EBOV) is a highly pathogenic filovirus which can result in Ebola virus disease (EVD); a serious medical condition that presents as flu like symptoms but then often leads to more serious or fatal outcomes. The 2013–16 West Africa epidemic saw an unparalleled number of cases. Here we show characterisation and identification of T cell epitopes in surviving patients from Guinea to the EBOV glycoprotein. We perform interferon gamma (IFNγ) ELISpot using a glycoprotein peptide library to identify T cell epitopes and determine the CD4+ or CD8+ T cell component response. Additionally, we generate data on the T cell phenotype and measure polyfunctional cytokine secretion by these antigen specific cells. We show candidate peptides able to elicit a T cell response in EBOV survivors and provide inferred human leukocyte antigen (HLA) allele restriction. This data informs on the long-term T cell response to Ebola virus disease and highlights potentially important immunodominant peptides.


2016 ◽  
Vol 339 (11-12) ◽  
pp. 517-528 ◽  
Author(s):  
Alexandre Hassanin ◽  
Nicolas Nesi ◽  
Julie Marin ◽  
Blaise Kadjo ◽  
Xavier Pourrut ◽  
...  

Author(s):  
Nadege Goumkwa Mafopa ◽  
Gianluca Russo ◽  
Raoul Emeric Guetiya Wadoum ◽  
Emmanuel Iwerima ◽  
Vincent Batwala ◽  
...  

A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of the 2013-2016 epidemic in West Africa may cause mild or asymptomatic infection in a proportion of cases, possibly due to an efficient immune response.


2014 ◽  
Vol 45 (1) ◽  
pp. 2-5 ◽  
Author(s):  
Colin Brown ◽  
Paul Arkell ◽  
Sakib Rokadiya

2018 ◽  
Vol 200 ◽  
pp. 166-173 ◽  
Author(s):  
Jesse Bonwitt ◽  
Michael Dawson ◽  
Martin Kandeh ◽  
Rashid Ansumana ◽  
Foday Sahr ◽  
...  

Author(s):  
Clement Adebajo Meseko ◽  
Adeniyi Olugbenga Egbetade ◽  
Shamsudeen Fagbo

2019 ◽  
Vol 25 (11) ◽  
pp. 1307-1314 ◽  
Author(s):  
A.M. Rojek ◽  
A. Salam ◽  
R.J. Ragotte ◽  
E. Liddiard ◽  
A. Elhussain ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document